Singapore markets close in 2 hours 36 minutes
  • Straits Times Index

    3,094.12
    -4.13 (-0.13%)
     
  • Nikkei

    27,753.37
    -182.25 (-0.65%)
     
  • Hang Seng

    23,718.12
    +59.20 (+0.25%)
     
  • FTSE 100

    7,168.68
    +109.23 (+1.55%)
     
  • BTC-USD

    56,654.14
    -430.24 (-0.75%)
     
  • CMC Crypto 200

    1,438.28
    -30.80 (-2.10%)
     
  • S&P 500

    4,513.04
    -53.96 (-1.18%)
     
  • Dow

    34,022.04
    -461.68 (-1.34%)
     
  • Nasdaq

    15,254.05
    -283.64 (-1.83%)
     
  • Gold

    1,777.70
    -6.60 (-0.37%)
     
  • Crude Oil

    66.39
    +0.82 (+1.25%)
     
  • 10-Yr Bond

    1.4340
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,494.04
    -2.89 (-0.19%)
     
  • Jakarta Composite Index

    6,567.96
    +60.29 (+0.93%)
     
  • PSE Index

    7,032.54
    +85.48 (+1.23%)
     

Cresco Labs Opens Sunnyside in Oakland Park, Florida, 40th Dispensary Nationwide

  • Oops!
    Something went wrong.
    Please try again later.
·5-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

CHICAGO, October 27, 2021--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco Labs" or "the Company"), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the opening of a new Sunnyside dispensary in Oakland Park, Florida. Oakland Park is Cresco Labs’ second location in Broward County, fifth in South Florida, 11th in Florida and 40th nationwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211027005273/en/

Sunnyside Oakland Park marks Cresco Labs’ second store in Broward County, 11th in Florida and 40th nationwide. (Photo: Business Wire)

"Oakland Park marks our 40th Sunnyside dispensary nationwide as we continue to go deeper in strategic states to bring our award-winning brands to more patients and consumers every day," said Charlie Bachtell, CEO and Co-founder of Cresco Labs. "We’ve proven in both adult-use and medical markets like Illinois and Pennsylvania that when consumers have choice, our products are some of the most sought-after. I look forward to expanding access to these products across the state of Florida and taking market share."

Sunnyside Oakland Park is located at 499 E Oakland Park Blvd. The dispensary is near a Publix supermarket and minutes away from the I-95 highway, making it very accessible to daily commuters.

Sunnyside Oakland Park will serve patients with a medical card issued by the state of Florida. Patients can place orders online through the Sunnyside.shop website or utilize next-day delivery. Orders can also be placed both in-store or via phone at 877-395-1009. Regular store hours are Monday through Saturday, 10AM to 8PM, and Sunday, 10AM to 5PM.

About Cresco Labs Inc.

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods ("CPG") approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Forward Looking Statements

This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under "Risk Factors" in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211027005273/en/

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Jake Graves, Cresco Labs
Manager, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting